Cargando…
Predictive factors for cardiac conduction abnormalities with hydroxychloroquine-containing combinations for COVID-19
This longitudinal, prospective cohort study aimed to assess risk of QTc interval prolongation and its predicting factors in subjects treated with combinations containing hydroxychloroquine (HCQ) for COVID-19. Moderate-to-severe QTc prolongation during therapy was defined as a QTc interval >470 ms...
Autores principales: | Padilla, Sergio, Telenti, Guillermo, Guillén, Lucía, García, José A., García-Abellán, Javier, Ding, Carolina, Mora, Antonia, García-Pachón, Eduardo, Gutiérrez, Félix, Masiá, Mar |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Ltd and International Society of Antimicrobial Chemotherapy.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7444635/ https://www.ncbi.nlm.nih.gov/pubmed/32853675 http://dx.doi.org/10.1016/j.ijantimicag.2020.106142 |
Ejemplares similares
-
Preemptive interleukin-6 blockade in patients with COVID-19
por: Guillén, Lucía, et al.
Publicado: (2020) -
Impact of the Addition of Baricitinib to Standard of Care Including Tocilizumab and Corticosteroids on Mortality and Safety in Severe COVID-19
por: Masiá, Mar, et al.
Publicado: (2021) -
Impact of interleukin-6 blockade with tocilizumab on SARS-CoV-2 viral kinetics and antibody responses in patients with COVID-19: A prospective cohort study
por: Masiá, Mar, et al.
Publicado: (2020) -
SARS-CoV-2 Seroconversion and Viral Clearance in Patients Hospitalized With COVID-19: Viral Load Predicts Antibody Response
por: Masiá, Mar, et al.
Publicado: (2021) -
Short-term Increase in Risk of Overweight and Concomitant Systolic Blood Pressure Elevation in Treatment-Naïve Persons Starting INSTI-Based Antiretroviral Therapy
por: Galdamez, Ronald, et al.
Publicado: (2019)